DelveInsight provides the intelligent information to Business and Healthcare professionals through the analytical and strategic Reports. Currently we have 3000+ Marketed and Pipeline Reports in the Market. These Reports are based on Indication, Mechanism of Actions, Drugs, Global API Manufacturers and Specialized Reports on Onco-Immunology, Orphan Diseases, Biologics & Biosimilars, Gene Therapy, Stem Cells Therapy and other upcoming areas. This platform is used by many companies to transform and redefine their businesses.
DelveInsight, with the expertise over therapeutic areas have a database of 600+ Indication Reports. We serve clients by providing insights over pipeline drugs across the drug value chain. These Reports provides the detailed product/company profiles, pre-clinical and clinical competitive intelligence, licensing information, collaborations, technology, therapeutic assessments based on molecule type, route, monotherapies and combination therapies. DelveInsight Strategic Report helps clients in informed decision making.
DelveInsight, the target analysis specialist, offers Reports across 670+ different targets and 700+ different mechanism of action across the therapeutic areas. These Reports provides deep insights of therapeutics, targeting the specific mechanism of action and the intelligence involved across MoA to the Biopharmaceutical companies across the globe.
Drug Insights report provides details of marketed drugs and API Manufacturers across the globe. The report covers the Global Market Assessment of the drug which includes total sales estimation and also provides the forecasted sales performance. Report also covers the detailed clinical assessment, patent's information and market exclusivity data. Currently, we have 400+ Report in the market which covers marketed drug including small molecules and biologics.
DelveInsight assists Generic and Drug Development Companies by providing insight about Active Pharmaceutical Ingredients (API) manufacturers. DelveInsight provides the insight through two kind of reports; Drug and Indication API Insight which covers around 400+ drugs and indications respectively. These Reports gives complete insights on marketed drugs along with Global API Manufacturers across Europe, US, India and China. The Report also covers Phase III pipeline information for specific indication.
We have entered into an era where technologies have enriched/replaced the existing therapies and provided them with more specific approach which resulted into better safety and efficacy. With the motive of providing clients with potential therapies intelligence, DelveInsight has launched Strategic Reports on Immuno-Oncology, Gene Therapy, Stem Cells Therapy, Antibody-Drug Conjugates and many more. It provides unlimited data potential and extensive applications including therapeutics detailed profiles, market size, progress tracking, benchmarking against competitors, understanding reasons behind success / failure of therapeutics and designs strategy accordingly. DelveInsight Special Reports helps clients to transform insights into a distinctive competitive advantage.
In addition to this, DelveInsight provides client unsurpassed flexibility of getting the report customized according to their requirements.